Panel Member: Jeff Stahmann

Photo
Position
Senior Fellow in Research and Development
Affiliation
Boston Scientific

Bio

Jeffrey E. Stahmann received his B.S. degree in electrical engineering in 1978 and M.S. degree in electrical engineering in 1985 from the University of Wisconsin-Madison and University of Minnesota-Twin Cities respectively.

Jeffrey is a Senior Fellow in Research and Development within Boston Scientific’s Rhythm Management Division – the division within the corporation focused on diagnosing and treating electrical conditions of the heart.   He currently leads medical science and technology exploratory activities for the division.  The role comprises identification and exploration of unmet medical needs and new technology applicable to electrically active medical devices.

He has almost 30 years of experience as a development engineer and research scientist on implantable medical devices and has held multiple leadership positions.  His work has concentrated on electrically active implantable devices for cardiac therapy and diagnosis including pacemakers, defibrillators, cardiac resynchronizers, ECG recorders and pressure sensors.  Prior to his career in medical devices he designed custom integrated circuits for various aerospace applications and US government agencies.

Jeffrey has been issued over 300 US patents for electrical and mechanical design, materials, sensors and algorithms relating to medical devices.

 

Sensors, Actuators and Data Management in Medical Devices

For many decades medical devices have used various sensors to monitor patient conditions. In some cases they directly control medical therapy.  Rapid advances in sensor, integrated circuit, communication and actuator technologies have the potential to profoundly improve the capability of medical devices. 

Sensor, and even more so actuator, technology in fully implantable medical devices has historically been limited due to size, energy and bio-compatibility concerns.  Advances in MEMS and bio-technology are reducing these barriers.  Recently regulatory approvals have been achieved for implantable medical devices with new sensing modalities.  At the same time extracorporeal (e.g. wearable, holdable) medical devices have become ubiquitous, fueled by consumer electronics connectivity and mobile sensor technology.

Many chronic medical conditions such as diabetes, heart failure and Parkinson's disease already benefit from ambulatory therapy from medical devices.  How can improved sensor and actuator technology improve management of these conditions?  What role will advancing sensor technology play in providing benefit to many other under-managed chronic medical conditions in need of ambulatory monitoring and autonomous therapy?  The presentation will touch on these questions as sensors are employed to improve the quality and quantity of life in the future.

Sponsors